Related Experiment Video
Updated: Apr 14, 2026

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery
Published on: January 31, 2017
Targeted Drug Delivery for Cardiovascular and Cerebrovascular Diseases
1Department of Pharmaceutics, College of Pharmacy, Shandong University, 44 Wenhua Xilu, Jinan 250012, China. professorgxzhai@126.com.
Abstract:
Cardiovascular and cerebrovascular diseases (CCVD) are a major and increasing health burden worldwide. Although treatments have been made a certain progress, the development of novel therapies for patients remains a major research object. There are a lot of drugs against CCVD, but most of them lack tissue specificity with a short half-life, which seriously limits their extensive clinical application. Utilization of some pathophysiological changes caused by CCVD, targeted drug distribution in CCVD patients could be achieved. The current review aims to capture various drug delivery systems transporting drug specifically to vascular disease, including passive, active and physicochemical targeted delivery carriers. Their design strategies and mechanisms are described in detail. The present limitations and future perspective are also discussed.
Insights
Novel drug delivery systems offer targeted treatments for cardiovascular and cerebrovascular diseases (CCVD). These systems improve drug specificity and half-life, overcoming limitations of current therapies for better clinical application.
Area of Science:
- Biomedical Engineering
- Pharmacology
- Cardiology
Background:
- Cardiovascular and cerebrovascular diseases (CCVD) represent a significant global health challenge.
- Current CCVD treatments often lack tissue specificity and have short half-lives, limiting their clinical efficacy.
Purpose of the Study:
- To review advanced drug delivery systems for targeted CCVD therapy.
- To explore strategies for enhancing drug specificity and therapeutic outcomes in vascular diseases.
Main Methods:
- Review of passive, active, and physicochemical targeted drug delivery carriers.
- Analysis of design strategies and mechanisms for CCVD drug targeting.
- Discussion of current limitations and future prospects in targeted CCVD therapy.
Main Results:
- Various targeted drug delivery systems (passive, active, physicochemical) can specifically target vascular diseases.
- These systems leverage CCVD-induced pathophysiological changes for improved drug distribution.
- Design strategies and mechanisms for targeted delivery are detailed.
Conclusions:
- Targeted drug delivery systems hold significant promise for advancing CCVD treatment.
- Overcoming limitations of current therapies through enhanced specificity and prolonged drug action is achievable.
- Further research into these systems is crucial for future clinical applications.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

